Chemotherapy of Metastatic Neuroendocrine Tumors With Aranose in Monoregimen and in Combination With Capecitabine and Temozolomide.

Malignant tumours
doi 10.18027/2224-5057-2013-1-47-55
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Russian Society of Clinical Oncology

Related search

Randomized Trial of the Combination of Lomeguatrib and Temozolomide Compared With Temozolomide Alone in Chemotherapy Naive Patients With Metastatic Cutaneous Melanoma

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2007English

Identification of Primary Tumors in Patients Presenting With Metastatic Gastroenteropancreatic Neuroendocrine Tumors

Surgery
Surgery
2017English

Systemic Chemotherapy With FOLFOX in Metastatic Grade 1/2 Neuroendocrine Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2016English

Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer

Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
2011English

Combination of 6-Thioguanine, Capecitabine, and Celecoxib With Temozolomide or Lomustine for Recurrent High-Grade Glioma

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2010English

Patterns of Care Among Real‐World Patients With Metastatic Neuroendocrine Tumors

Oncologist
Cancer ResearchMedicineOncology
2019English

Chemotherapy-Associated Steatohepatitis With Temozolomide and Dexamethasone

Canadian Journal of Neurological Sciences
MedicineNeurology
2012English

Combination Chemotherapy in Metastatic Breast Cancer

BMJ
1977English

Temozolomide Combined With Capecitabine in the Treatment of Mixed Neuroendocrine Carcinoma of the Lung With Poor Tolerance After Repeated Radiochemotherapy: A Case Report and Literature Review

OncoTargets and Therapy
OncologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy